RSS-Feed abonnieren
DOI: 10.1055/s-0038-1656112
Factor XIII Deficiency due to a Leu660Pro Mutation in the Factor XIII Subunit-a Gene in Three Unrelated Palestinian Arab Families
Publikationsverlauf
Received 04. Oktober 1996
Accepted after revision 05. März 1997
Publikationsdatum:
26. Juli 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/199706/lookinside/thumbnails/10-1055-s-0038-1656112-1.jpg)
Summary
In this report we describe the molecular basis of FXIII a-subunit deficiency in three unrelated Palestinian Arab families. In three patients representing each family two substitutions were identified in exon 14 on both alleles: C to G change resulting in a Gln651Glu substitution (a previously described polymorphism) and a T to C transition causing Leu660Pro substitution. The latter is a new mutation which creates a restriction site for FnuDII enzyme. Restriction analysis performed in members of the three families clearly distinguished between severely affected patients, obligate carriers and unaffected subjects. A population survey failed to detect the mutation among 250 Jewish individuals but did detect two heterozygotes among 300 Arabs suggesting a 0.0033 frequency for the Pro660 allele in this population. In two out of the three families the Pro660 allele was linked to allele 5 of the 5’ short tandem repeat polymorphism within the FXIII a-subunit gene suggesting that the mutation might have occurred at least twice. cDNA obtained from mRNA isolated from patients’ platelets and monocytes appeared similar in size to that of normal control indicating that the Leu660Pro mutation does not affect mRNA synthesis. Computer modeling based on cristallographic studies of the a-subunit of factor XIII predicted that the mutant protein is expected to misfold into a structure which is either unstable or susceptible to degradation.
-
References
- 1 Lorand L, Losowsky MS, Miloszewski KJM. Human factor XIII: Fibrin-stabilizing factor. Prog Hemostasis Thromb 1980; 05: 245-90
- 2 Lorand L, Jacobsen A. Accelerated lysis of blood clots. Nature 1962; 195: 911-912
- 3 Shen LL, Lorand L. Contribution of fibrin stabilization to clot strength. J Clin Invest 1983; 71: 1336-1341
- 4 Mary A, Achyuthan KE, Greenberg CS. B-chains prevent the proteolytic inactivation of the a-chains of plasma factor-XIII. Biochim Biophys Acta 1988; 966: 328-335
- 5 Poon MC, Russell JA, Low S, Sinclair GD, Jones AR, Jones AR, Blahey W, Ruether BA, Hoar DI. Hemopoietic origin of factor XIIIA subunits in platelets, monocytes and plasma. J Clin Invest 1989; 84: 787-792
- 6 Henriksson P, Becker S, Lynch G, McDonagh J. Identification of intracellular factor XIII in human monocytes and macrophages. J Clin Invest 1985; 76: 528-534
- 7 Muszbek L, Adany R, Szegedi G, Polgar J, Kavai M. Factor XIII of blood coagulation in human monocytes. Thromb Res 1985; 37: 401-410
- 8 Adany R, Belkin A, Vasilevska T, Muszbek L. Identification of blood coagulation factor XIII in human peritoneal macrophages. Eur J Cell Biol 1985; 38: 171-173
- 9 Weisenberg LJ, Shiu DT, Conkling PR, Shulman MA. Identification of normal human peripheral blood monocytes and liver as sites of synthesis of coagulation factor XIIIA-chain. Blood 1987; 70: 579-582
- 10 Board PG, Webb GC, McKee J, Ichinose A. Localization of the coagulation factor XIIIA subunit gene (FI3A) to chromosome bands 6p24-→p25. Cytogenet Cell Genet 1988; 48: 25-27
- 11 Webb GC, Coggan M, Ichinose A, Board PG. Localization of human coagulation factor XIIIB gene (F13B) to chromosome bands lq 31 32. 1. Coagulation and restriction fragment polymorphism of the locus. Hum Genet 1989; 81: 157-160
- 12 Ichinose A, Hendrickson LR, Fujikawa K, Davie EW. Amino acid sequence of the A subunits of human factor XIII. Biochemistry 1986; 25: 6900-6906
- 13 Ichinose A, Bottenus RE, Davie EW. Structure of transglutaminases. J Biol Chem 1990; 265: 13411-13414
- 14 Grundman U, Amann E, Zettemeissl G, Rupper HA. Characterization of cDNA coding for human factor XIIIA. Proc Natl Acad Sci USA 1986; 83: 8024-8028
- 15 Ichinose A, Davie EW. Characterization of the gene for the A subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor. Proc Natl Acad Sci USA 1988; 85: 5829-5833
- 16 Yee VC, Pedersen LC, Le TrongI, Bishop P, Stenkamp RE, Teller DC. Three-dimensional structure of a transglutaminase human blood coagulation factor XIII. Proc Natl Acad Sci USA 1994; 7296-7300
- 17 Bottenus RE, Ichinose A, Davie EW. Nucleotide sequence of the gene for the b-subunit of human factor XIII. Biochemistry 1990; 29: 111-195
- 18 Board P, Coggan M, Miloszewski K. Identification of a point mutation in factor XIIIA subunit deficiency. Blood 1992; 80: 937-941
- 19 Kamura T, Okanura T, Murakawa M, Tsuda H, Teshima T, Shibuya T. Deficiency of coagulation factor XIIIA subunit caused by the dinucleotide deletion at the 5’ end of exon III. J Clin Invest 1992; 90: 315-319
- 20 Standen GT, Bowen DJ. Factor XIII Abrist0ll: Detection of a nonsense mutation (Arg171→stop codon) in factor XIII A subunit deficiency. Br J Haematol 1993; 85: 769-772
- 21 Mikkola H, Syrjala M, Rasi V, Vahtera E, Hamalainen E, Peltonen L, Palotie A. Deficiency in the A-subunit of coagulation factor XIII: Two novel point mutations demonstrate different effects on transcript levels. Blood 1994; 84: 517-525
- 22 Coggan M, Baker R, Miloszewski K, Woodfield G, Board P. Mutations causing coagulation Factor XIII subunit A deficiency: Characterization of the mutant proteins after expression in yeast. Blood 1995; 85: 2455-2460
- 23 Anwar S, Stewart AD, Miloszewski KJ, Losowsky MS. Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function. Br J Haematol 1995; 91: 728-735
- 24 Vreken P, Niessen RWLW, Peters M, Schaap MC, Zuithoff-Rijntjes JG, Sturk A. A point mutation in an invariant splice acceptor site results in a decreased mRNA level in a patient with severe coagulation factor XIII subunit A deficiency. Thromb Haemost 1995; 74: 584-589
- 25 Mikkola H, Yee VC, Syrjala M, Seitz R, Egbring R, Petrini P, Ljung R, Ingerslev J, Teller DC, Peltonen L, Palotie A. Four novel mutations in deficiency of coagulation factor XIII: Consequences to expression and structure of the A-subunit. Blood 1996; 87: 141-151
- 26 Aslam S, Poon M-C, Yee VC, Bowen DJ, Standen GR. Factor XIII-ACalgary: a candidate missense mutation (Leu667Pro) in the beta barrel 2 domain of the factor XIIIAsubunit. Br J Haematol 1995; 91: 452-457
- 27 Kangsadalampai S, Farges-Berth A, Hande CaglayanS, Board PG. New mutations causing the premature termination of translation in the A subunit gene of coagulation factor XIII. Thromb Haemost 1996; 76: 139-142
- 28 Saito M, Asakura H, Yoshida T, Iro K, Okafugi L, Matsuda T. A familial factor XIII subunit B deficiency. Br J Haematol 1990; 74: 290-294
- 29 Girolami A, Burul A, Fabris F, Cappellato G, Betterle C. Studies on factor XIII antigen in congenital factor XIII deficiency. A tentative classification of the disease in two groups. Folia Hematol 1978; 105: 131-141
- 30 Izumi T, Hashiguchi T, Castaman G, Tosetto A, Rodeghiero F, Girolami A, Ichinose A. Type I factor XIII deficiency is caused by a genetic defect of its b subunit: Insertion of triplet AAC in exon 11 leads to premature termination in the second Sushi domain. Blood 1996; 87: 2769-2774
- 31 Hashiguchi T, Saito M, Morishita E, Matsuda T, Ichinose A. Two genetic defects in a patient with complete deficiency of the b-subunit for coagulation factor XIII. Blood 1993; 82: 145-150
- 32 Berliner S, Lusky A, Zivelin A, Modan M, Seligsohn U. Hereditary factor XIII deficiency: Report of four families and definition of the carrier state. BrJ Haematol 1984; 56: 495-505
- 33 Kunkel LM, Smith KD, Boyer SH, Borgaonker DS, Watchel SS, Miller DJ, Breg WR, Jones HW, Rary JM. Analysis of human Y-chromosome specific reiterated in chromosome variants. Proc Natl Acad Sci USA 1977; 74: 1245-1249
- 34 Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1986; 86: 2766-2770
- 35 Puers C, Hammond HA, Caskey T, Lins AM, Sprecher CJ, Brinkmann B, Schumm JW. Allelic ladder characterization of the short tandem repeat polymorphism located in the 5’flanking region to the human coagulation factor XIIIA subunit gene. Genomics 1994; 23: 260-261
- 36 Brunger AT, Kuriyan J, Karplus M. Crystallographic R factor refinement by molecular dynamics. Science 1987; 235: 458-460
- 37 Jones TA, Zou J-Y, Cowan SW, Kjelgaard M. Improved methods for building models in electron density maps and location of errors in these models. Acta Crystallogr 1991; 47: 110-119
- 38 Kraulis PJ. MOLSCRIPT, a program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr 1991; 24: 946-950
- 39 Merritt EA, Murphy MEP. Raster 3D Version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr 1994; 50: 869-873
- 40 Scozzari R, Cruciani F, Santolamazza P, Sellitto D, Modiano D, Cai W. Allelic association between the HUMF13A01 (AAAG)nSTR locus and a nearby two-base insertion/deletion polymorphic marker. Am J Hum Genet 1995; 56: 1005-1006